Introduction
The purpose of this report is to describe the utilization 'analgesic drugs in office-based ambulatory care. The report ]bines the 1980 and 1981 findings of the National Ambula * y Medical Care Survey, an annual, sample survey of otTice based physicians conducted from 1973 through 198I by the National Center for Health Statistics. The National Ambulatory Medical Care Survey (NAMCS ) is scheduled to take the tleld again in 19S5and every third year following.
The term utilisation is limited to the ordering or providing of an analgesic drug by the otllce-based physician in the course of an office visit. It does not include drugs ordered by phone contact, nor does it attempt to measure ultimate patient compliance with the doctor's instruction.
The drugs described are those classified as Central iVerv ous System Drugs: Analgesics and Antipyretics, according to the American Hospital Forrnulary Service Classitlcation System. ] Description centers on drugs of this class that were named by physician respondents in 1980-81. A list of the named analgesics appears in figure 1. Along with all ne}~t analgesics ordered or provided, the physician also recorded continued analgesics if the patient was specifically instructed during the visit to continue the medication. (However, the data base does not distinguish between the new and the continued medication. ) The listed agents appear as brand2 or generic names, depending on the choice made by the physician in ordering the analgesic. They are divided into two subcategories:~ � Opioids: Produce analgesia by their interaction with spe cific opioid binding sites in the central nervous system. (The terms "opioid" and "opiate" are interchangeable).
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Nonopioids: Do not bind to the opioid receptors. (Indeed, the exact mechanism of their analgesic action remains unknown}.
By restricting its scope to an arbitrarily selected class of analgesics this study understates the overall use of pain-re lieving drugs in office practice. For example, it does not account for the presence of analgesic ingredients in drugs primarily classified under other rubrics, as in the following cases:
. Because the estimates presented in this report are based on a sample of office visits and drug mentions rather than the entire universe of visits and mentions. they are subject to sampling variability. The technical notes at the end of the report provide a brief description of the sample design, an explanation of sampling errors, and guidelines for judging the precision of the estimates. The remaining 85,261,000 (73 percent) were nonopioids.
11 Butazolidin alka (phenylbutezone, Table 2 describes some key dimensions of the analgesic drugs.
Drug dimensions
Entry status-In ordering an analgesic, physicians showed a strong tendency to favor brand name choices over their generic counterparts. About 4 of every 5 of the overall class were identified by trade name. The tendency was strongest in the opioid subclass; here, only 1 of every 10 mentions was generically identified.
Prescription stares-The utilization of nonprescription drugs, apparent in 27 percent of analgesic mentions, was more than double their proportionate use in overall, officebased drug therapy (12 percent).
Control status-Because of its opioid component, the analgesic family has a substantial proportion of controlled agents among its members. Controlled agents accounted for 26 percent Of analgesic mentions, the majority of their number classified in Schedules III and IV. Thus the prescribing physi cian, faced with the need to moderate pain, also needs to weigh the desired therapeutic effect against the potential haz ards of dependence or habituation.
Composition status
The proportionate use of combination products among analgesics (apparent in about 26 percent of mentions)
Qonf orms closely to the proportionate use of combinations throughout office-based drug therapy. By far the most common analgesic mixtures involved the combination of an opioid with a nonopioid, with codeine or propoxyphene appearing as the most common opioid ingredient. Ample support for the use of this type of analgesic combination is provided by the AMA Drug Et'aluations, Fzj?h Edition:
The combination of an opiate or opioid with a nonopiate (analgesic-antipyretic) appears to be rational because the mechanism of action of each drug differs and the results of controlled studies have shown that the analgesic effects of the individual drugs are additive. Since the nonopiates have a ceiling analgesic effect and the dosage of opiates should be limited to prevent adverse effects, a combination of this type may provide greater pain relief with a minimum of adverse effects in a con venient form for the patient.4 Apparent in only 6 percent of analgesic mentions, the combina tion of a nonopioid with another nonopioid is manifestly uncommon in the office-based utilization of analgesics, possi bly because of the reason stated in AMA Drug Evaluations, F[~th Edition: ".. . it can be concluded that mixtures of analgesic-antipyretic drugs with or without caffeine have not been proved to be superior to optimal doses of their individual components."~
Diagnosis
By far the most intensive use of analgesic therapy occurs within two diagnostic groups: "Injuries" and "Diseases of the Musculoskeletal System" (table 3) .5 This is demonstrated more clearly in the following listing of the specific conditions most frequenti y associated with analgesic utilization:
Opioid therapy

Rank
Diagnosis and ICO-9-CM Codes In contrast to other drug classes, the rate of analgesic utilization in the category "Symptoms and ill-defined condi tions" is relatively higher, documenting the physician's ten dency to respond to symptomatic pain in advance of a clearly established diagnosis. However, it would be a mistake to assume that an analgesic is automatically ordered whenever pain appears as a symptom. Indeed, according to another NAMCS study (in preparation), about 70 percent of nearly 70 million newly encountered problems where pain was the chief presenting symptom did not involve the use of an inscope analgesic.
'AMADrag Erulaa2ions, op cit, p 10 I.
TBa.wd on International Classification of l)iseases, 9th Revision, Clinical
Modijkofion (lCD-9-CM ). .
� 6 aciwncedata
The significantly higher rate among black office patients Physician characteristics (table 5) is chiefly related to the finding that black patients suffered proportionately more than white patients from the Of the most-visited, office-based specialities, five exfour conditions that command the highest rates of analgesic ceeded the average rate of analgesic utilization ( The most conservative utilization of analgesics occurred
with new patients (table 7) , a pattern common throughout
."
all office-based drug therapy. The most intensive use occurred
when a new problem was presented by a patient with whom 'Because it was possible to use more than one form of nonmedication therapy at a given visit, estimates will exceed the totals at the top of the columns. 'An analgasic visit is an office visit at which one or more analgesic agents was utilized.
Co-occurrence
Utilized at 62 percent of all office visits, drug therapy (of all types) is by far the most frequent form of treatment provided in office practice. Further, when they do use a drug, physicians tend to use more than one. The overall average is about two drugs per drug visit, but larger multiples are not uncommon, especially when the patient suffers from more than one disorder. With co-occurrence the rule rather than the exception, it is instructive to explore the patterns of concomitant utilization of drugs that occurred in the office visits at which an analgesic agent was ordered or provided.
At the 106.7 million visits at which an analgesic agent was utilized, its use (expressed as a percent of these visits) co-occumed most frequently with the use of one or more members of the following ten therapeutic families: 
Technical notes Source of data and sample design
The estimates presented in this report are based on the findings of the National Ambulatory Medical Care Survey (NAMCS), a sample survey of office-based care conducted annually from 1973 through 198 I by the National Center for Health Statistics. The target universe of NAMCS is com posed of office visits made by ambulatory patients to non-Fed eral and noninstitutional physicians who are principally engaged in office-based, patient-care practice. Visits to physi cians practicing in Alaska and Hawaii are excluded from the range of NAMCS, as are visits to anesthesiologists, pathologists, and radiologists.
NAMCS uses a multistage probability sample design that involves a step sampling of primary sampling units (PSU'S), physicians' practices within PSU'S, and patient visits within physicians' practices. The physician sample (5,805 physicians for 1980 and 1981 ) was selected from master files maintained by the American Medical Association and the American Osteopathic Association. Those members of the sample who proved to be inscope and eligible participated at a rate of 77.3 percent. Responding physicians completed visit records for a systematic random sample of office visits made during a randomly assigned weekly reporting period. Telephone contacts were excluded. During 1980 and 1981 responding physicians completed 89,447 visit records on which they recorded 97,796 drug mentions. Characteristics of the physician's practice, such as primary specialty and type of practice, were obtained during an induction interview. The National Opinion Research Center, under contract to the National Center for Health Statistics, was responsible for the field operations of the survey. 
Sampling errors and rounding
The standard error is ameasure of the sampling variabilit that occurs by chance because only a sample, rather th the entire universe, is surveyed. The relative standard erro m of an estimate is obtained by dividing the standard error by the estimate itself and is expressed as a percent of the estimate. In this report, any estimate that exceeds a relative standard error of 30 percent is marked with an asterisk. Table I should be used to obtain the relative standard error for aggregates of office visits or for mentions of drugs by specific name (for example, Darvon). Table II should be used to obtain the relative standard error for drug mentions expressed as drug groups (for example, the analgesic drug family).
In the tables of this report estimates have been rounded to the nearest thousand. For this reasons, detailed estimates do not always add to totals. Example of use of table: An aggregate estimate of 30,000,000 drug mentions has a relative standard error of 7.0 percent or a standard error of 2,100,000 mentions (7.0 percent of 30,000,000 mentions).
Definitions
An ofiice is a place that physicians identify as a location for their ambulatory practice. Responsibility for patient care and professional services rendered in an office resides with the individual physician rather than an institution.
A L'isiris adirect personal exchange between anambula tory patient seeking health care and a physician, or staff member working under thephysician's supervision, who pro vides the health services.
A drug rrrerztiorr is tlie physician's entry on the vis" record of a pharmaceutical agent ordered or provided any route of administration for prevention, diagnosis, ortrea 0 ment. Generic as well as brand-name drugs are included, 
